FLHKII-pGFPN3 Citations (10)
Originally described in: Glucose phosphorylation and mitochondrial binding are required for the protective effects of hexokinases I and II.Sun L, Shukair S, Naik TJ, Moazed F, Ardehali H Mol Cell Biol. 2008 Feb . 28(3):1007-17. PubMed Journal
Articles Citing FLHKII-pGFPN3
| Articles |
|---|
| Hexokinase 2 controls cellular stress response through localization of an RNA-binding protein. Courteau L, Crasto J, Hassanzadeh G, Baird SD, Hodgins J, Liwak-Muir U, Fung G, Luo H, Stojdl DF, Screaton RA, Holcik M. Cell Death Dis. 2015 Aug 6;6:e1837. doi: 10.1038/cddis.2015.209. PubMed |
| Gen-27, a newly synthesized flavonoid, inhibits glycolysis and induces cell apoptosis via suppression of hexokinase II in human breast cancer cells. Tao L, Wei L, Liu Y, Ding Y, Liu X, Zhang X, Wang X, Yao Y, Lu J, Wang Q, Hu R. Biochem Pharmacol. 2017 Feb 1;125:12-25. doi: 10.1016/j.bcp.2016.11.001. Epub 2016 Nov 3. PubMed |
| Regulation of glycolytic metabolism by autophagy in liver cancer involves selective autophagic degradation of HK2 (hexokinase 2). Jiao L, Zhang HL, Li DD, Yang KL, Tang J, Li X, Ji J, Yu Y, Wu RY, Ravichandran S, Liu JJ, Feng GK, Chen MS, Zeng YX, Deng R, Zhu XF. Autophagy. 2018;14(4):671-684. doi: 10.1080/15548627.2017.1381804. Epub 2017 Dec 17. PubMed |
| Real-Time Imaging of Mitochondrial ATP Dynamics Reveals the Metabolic Setting of Single Cells. Depaoli MR, Karsten F, Madreiter-Sokolowski CT, Klec C, Gottschalk B, Bischof H, Eroglu E, Waldeck-Weiermair M, Simmen T, Graier WF, Malli R. Cell Rep. 2018 Oct 9;25(2):501-512.e3. doi: 10.1016/j.celrep.2018.09.027. PubMed |
| Non-proteolytic ubiquitination of Hexokinase 2 by HectH9 controls tumor metabolism and cancer stem cell expansion. Lee HJ, Li CF, Ruan D, He J, Montal ED, Lorenz S, Girnun GD, Chan CH. Nat Commun. 2019 Jun 14;10(1):2625. doi: 10.1038/s41467-019-10374-y. PubMed |
| Hexokinase 2 couples glycolysis with the profibrotic actions of TGF-beta. Yin X, Choudhury M, Kang JH, Schaefbauer KJ, Jung MY, Andrianifahanana M, Hernandez DM, Leof EB. Sci Signal. 2019 Dec 17;12(612). pii: 12/612/eaax4067. doi: 10.1126/scisignal.aax4067. PubMed |
| Forced expression of miR-143 and -145 in cardiomyocytes induces cardiomyopathy with a reductive redox shift. Ogawa K, Noda A, Ueda J, Ogata T, Matsuyama R, Nishizawa Y, Qiao S, Iwata S, Ito M, Fujihara Y, Ichihara M, Adachi K, Takaoka Y, Iwamoto T. Cell Mol Biol Lett. 2020 Aug 24;25:40. doi: 10.1186/s11658-020-00232-x. eCollection 2020. PubMed |
| NEDD9 sustains hexokinase expression to promote glycolysis. Deneka AY, Nikonova AS, Lee HO, Kruger WD, Golemis EA. Oncogenesis. 2022 Apr 11;11(1):15. doi: 10.1038/s41389-022-00391-w. PubMed |
| Mitochondrial control of microglial phagocytosis by the translocator protein and hexokinase 2 in Alzheimer's disease. Fairley LH, Lai KO, Wong JH, Chong WJ, Vincent AS, D'Agostino G, Wu X, Naik RR, Jayaraman A, Langley SR, Ruedl C, Barron AM. Proc Natl Acad Sci U S A. 2023 Feb 21;120(8):e2209177120. doi: 10.1073/pnas.2209177120. Epub 2023 Feb 14. PubMed |
| SOX4-SMARCA4 complex promotes glycolysis-dependent TNBC cell growth through transcriptional regulation of Hexokinase 2. Khanna P, Mehta R, Mehta GA, Bhatt V, Guo JY, Gatza ML. bioRxiv [Preprint]. 2023 Sep 13:2023.09.10.557071. doi: 10.1101/2023.09.10.557071. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.